Oral azacitidine (Onureg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral azacitidine (Onureg), covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS) [Phase 2, Phase 3]